| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695879 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
Our data suggest that morcellation increase the risk of death in patients affected by undiagnosed LMS. Further prospective studies are warranted in order to assess the risk to benefit ratio of power morcellator utilization in patients with apparent benign uterine myomas.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Francesco M.D., Giuseppa M.D., Giorgio M.D., Ph.D., Giovanni M.D., Stefano M.D., Pierandrea M.D., Myriam M.D., Giovanni M.D., Gennaro M.D., Stefano M.D., Alice M.D., Giuseppe M.D., Paolo Giovanni M.D., Domenica M.D., Ph.D.,